Die Universitätsmedizin in Bayern im Rahmen der COVID-19-Pandemie

Abstract

BACKGROUND: In early 2020 the German healthcare system was put into a state of emergency due to the coronavirus disease 2019 (COVID-19) pandemic. Bavaria had to deal with more severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections than any other German state during the first wave and currently has over 270,000 cases, accounting for about one fifth of all COVID-19 cases in Germany. The Bavarian Ministry of Interior together with the Bavarian Sate Ministry of Health and Care issued a general ruling at the beginning of the first wave that ordered the centralised organisation of hospital capacity, a redesign of the information technology (IT) management system and introduced reporting obligations for SARS-CoV-2/COVID-19. The goal of this analysis was to investigate the role that university hospitals played in the inpatient treatment of COVID-19 patients. METHODS: A retrospective evaluation of all inpatient COVID-19 cases that were reported through the "IVENA Sonderlage" (Ivena eHEALTH, [IVENA, interdisziplinärer Versorgungsnachweis, mainis IT-Service GmbH, Offenbach am Main, Germany]), a special module for the "Interdisciplinary Medical Care Capacity Management System" designed for extraordinary events and circumstances, was conducted by analysing the number of reported treatment days of all Bavarian hospitals that participated in the treatment of COVID-19 patients. RESULTS: During the first wave university hospitals provided relevant scientific contributions and played an important role in advising physicians, hospitals and politicians on the pandemic. In all, 20% of intensive care unit (ICU) and intermediate care (IMC) treatment days were provided by the university hospitals in particular for treatment of complex courses of COVID-19.